Immunize.org supports evidence-based vaccination recommendations and schedules. Read more at About Us.
  • RSV (Respiratory Syncytial Virus)
  • Vaccine Recommendations during Pregnancy

How do ACOG’s RSV recommendations for the 2026–27 season differ from CDC’s current clinical considerations?

The main difference is seasonal timing. The American College of Obstetricians and Gynecologists (ACOG) recommends maternal Abrysvo from September 1 through March 1 in most of the continental United States; CDC’s current window remains September 1 through January 31. Both use 32 weeks 0 days through 36 weeks 6 days’ gestation and do not recommend repeat maternal vaccination in a later pregnancy.

ACOG’s rationale for extending the option of using vaccine until March was based on recent RSV seasons extending longer into the spring. However, in February it is not possible to predict local RSV activity at the time of birth when vaccinating a woman up to 8 weeks before delivery. RSV preventive antibody products, if available and acceptable to the parent, have the advantage of providing immediate protection (or deferral) based on the actual RSV circulation conditions at the time of delivery. If the mother is unvaccinated and RSV is no longer circulating locally, then protection with an RSV preventive antibody can be delivered in the fall before the onset of the infant’s first full RSV season. If, however, RSV circulation is no longer an issue by the time of delivery, and the mother was vaccinated, then the infant would not be eligible for RSV preventive antibody in the fall when RSV begins to circulate again. For late season RSV protection in February, although ACOG maintains vaccination as an option, preventive antibody products have the advantage of enabling more precise timing of protection in response to RSV activity at the time of birth.

Because RSV vaccination requires administration a minimum of 2 weeks before delivery to be effective, ACOG and CDC recommend against vaccination if delivery is planned or likely within 2 weeks. In such cases, an RSV preventive antibody product should be administered after delivery.

See www.acog.org/clinical/guidance/practice-advisory/2023/09/maternal-respiratory-syncytial-virus-vaccination and https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/pregnant-people.html.

Last reviewed: November 8, 2026

This page was updated on .